Monday, Feb 22, 2010
The American Society of Clinical Oncology (ASCO) recently appointed Harbin Clinic Medical Oncologist, Dr. Melissa S. Dillmon to their Leadership Development Program. This prestigious appointment, only open to ten oncologists annually, offers participants training in valuable leadership skills and exposure to the roles and mission of ASCO. The Society also uses the Leadership Program to prepare oncologists for shaping the development of the future of cancer care.
Dr. Dillmon said, “I am excited to be a part of this program. Last year was the inaugural year and those chosen for the program were all part of prestigious academic institutions. I am honored to represent Harbin Clinic and community oncologists in Georgia.
ASCO is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.
ASCO is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.
This program is a one-year program that requires a time commitment for travel and training.
Through the Leadership Development Program, Dr. Dillmon will begin:
- Networking with ASCO leadership at the 2010 Annual Meeting in Chicago, IL Gaining proficiency with key ASCO research initiatives
- Participating in leadership boot camp at ASCO Headquarters
- Receiving first-hand advocacy experience on Capitol Hill in Washington, DC
Dr. Dillmon’s office is located at Harbin Clinic Medical Oncology. She received her Medical Doctorate degree from Wake Forest University; Winston-Salem, NC. She completed her residency at the University of Alabama in Birmingham. Dr. Dillmon completed her Fellowship in Hematology and Oncology at the Comprehensive Cancer Center at University of Alabama, She is board certified by the American Board of Internal Medicine (Internal Medicine & Medical Oncology). She is a member of the Medical Association of Georgia, the American Society of Clinical Oncology and a board member of GASCO.